Headache epidemiology and demographics
Headache Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Headache epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Headache epidemiology and demographics |
Risk calculators and risk factors for Headache epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The prevalence of cluster headache is approximately 3 to 150 per 100,000 individuals worldwide.*Worldwide Prevalence of patient with secondary headache is approximately 18%. The prevalence of Migraine headache is estimated to be 12 to 15 percent of general population.
Epidemiology and Demographics
Prevalence
- The prevalence of cluster headache is approximately 3 to 150 per 100,000 individuals worldwide.[1]
- Worldwide Prevalence of patient with secondary headache is approximately 18%.[2]
- The prevalence of Migraine headache is estimated to be 12 to 15 percent of general population.[3]
Age
- Patients of all age groups may develop headache.
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- Cluster headache usually affects women of the Aferican -American and Caucasians.[4]
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
}
References
- ↑ Wei DY, Yuan Ong JJ, Goadsby PJ (2018). "Cluster Headache: Epidemiology, Pathophysiology, Clinical Features, and Diagnosis". Ann Indian Acad Neurol. 21 (Suppl 1): S3–S8. doi:10.4103/aian.AIAN_349_17. PMC 5909131. PMID 29720812.
- ↑ Do TP, Remmers A, Schytz HW, Schankin C, Nelson SE, Obermann M; et al. (2019). "Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list". Neurology. 92 (3): 134–144. doi:10.1212/WNL.0000000000006697. PMC 6340385. PMID 30587518.
- ↑ Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001). "Prevalence and burden of migraine in the United States: data from the American Migraine Study II". Headache. 41 (7): 646–57. doi:10.1046/j.1526-4610.2001.041007646.x. PMID 11554952.
- ↑ Reed C, Gordon S (1966). "Anaemia and polycythaemia in haemorrhagic telangiectasia". Med J Aust. 1 (11): 449–51. doi:10.5694/j.1326-5377.1966.tb72472.x. PMID 5909131.